Progyny Expands its Clinical Leadership, adding Alan B. Copperman, M.D., FACOG as Medical Director

NEW YORK, Oct. 02, 2017 (GLOBE NEWSWIRE) — Progyny, the leading fertility benefits company, today announced that Alan B. Copperman, M.D., FACOG has joined the Company as Medical Director. In his role, Dr. Copperman will work closely with the executive team and medical advisory board to ensure that Progyny’s comprehensive benefits include the latest clinical technologies and best practices to increase treatment success by reducing time to pregnancy, reducing miscarriage rates and decreasing rate of multiples (twins). Dr. Copperman will also provide clinical oversight of other key functions within Progyny, including network credentialing and working closely with the Company’s Patient Care Advocate team to further develop its high-quality, concierge patient experience.

David Schlanger, CEO of Progyny, said, “We are honored to have Dr. Copperman, a world-renowned expert in reproductive health, join our team. Working with the nation’s leading employers, we are committed to expanding access to high-quality fertility preservation and infertility treatments. Together with Dr. Copperman, we share a vision to ensure that anyone who wants to have a child can do so successfully.”

Dr. Copperman said, “Progyny has been successful in driving expanded access to employer-sponsored fertility care. As a practicing clinician, I have seen Progyny’s unique approach empower patients to work with their doctors and make the best clinical decisions, free from financial constraints. It is exciting to become a part of the energy and excellence of the Progyny team.”  

Dr. Copperman is the Director of the Division of Reproductive Endocrinology and Infertility as well as the Vice-Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at The Icahn School of Medicine at Mount Sinai. Additionally, Dr. Copperman is a Co-Founder of RMA of New York, and serves as the IVF Program’s Managing Director. As an experienced and respected clinician, Dr. Copperman has published numerous manuscripts and book chapters on reproductive medicine, and has co-authored hundreds of scientific abstracts on infertility, in vitro fertilization, egg freezing, ovum donation and genetics. Dr. Copperman is frequently quoted in print and digital media and is featured on local and nationally-televised news shows. Dr. Copperman has been named to New York magazine’s list of Best Doctors sixteen years in a row, and Castle Connolly and SuperDocs have annually recognized Dr. Copperman as one of the top fertility doctors. Dr. Copperman is board certified in reproductive endocrinology and infertility as well as in obstetrics and gynecology, and is a fellow of the American College of Obstetricians and Gynecologists and of the American Society for Reproductive Medicine.

About Progyny:
Progyny is a leading fertility benefits company that combines service, science, technology and data to provide comprehensive value based fertility solutions for self-insured employers.

Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com. 

Media Contact: Jennifer Brandt
Jennifer.Brandt@Progyny.com
Phone: 646-930-4207  

Ads

You May Also Like

世界肺癌大会周三新闻发布会:PD-1/PD-L1进展和预防和治疗肺癌的干预措施

日本横滨, Oct. 19, 2017 (GLOBE NEWSWIRE) -- 国际肺癌研究协会(IASLC)第十八届世界肺癌大会(WCLC)的最终新闻发布会强调了围绕PD-1和PD-L1的发现的新进展 - 包括来自发现PD-1的研究人员的讨论 - 以及预防肺癌和改善肺癌患者生活质量的干预措施。 与PD-1发现相关的肺癌治疗创新 在1992年首次确定PD-1的日本教授Tasuku ...